Literature DB >> 27411430

The DIPP project: 20 years of discovery in type 1 diabetes.

Michael J Haller1, Desmond A Schatz2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27411430     DOI： 10.1111/pedi.12398

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN： 1399-543X            Impact factor:   4.866


× No keyword cloud information.
  12 in total

Review 1.  Immune Mechanisms and Pathways Targeted in Type 1 Diabetes.

Authors:  Laura M Jacobsen; Brittney N Newby; Daniel J Perry; Amanda L Posgai; Michael J Haller; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2018-08-30       Impact factor: 4.810

2.  Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience.

Authors:  Carla J Greenbaum; Cate Speake; Jeffrey Krischer; Jane Buckner; Peter A Gottlieb; Desmond A Schatz; Kevan C Herold; Mark A Atkinson
Journal:  Diabetes       Date:  2018-05-16       Impact factor: 9.461

3.  Coeliac disease in infants: antibodies to deamidated gliadin peptide come first!

Authors:  Michele Arigliani; Francesca Rech Morassutti; Martina Fabris; Paola Melli; Elio Tonutti; Paola Cogo
Journal:  Ital J Pediatr       Date:  2017-08-10       Impact factor: 2.638

4.  A longitudinal plasma lipidomics dataset from children who developed islet autoimmunity and type 1 diabetes.

Authors:  Santosh Lamichhane; Linda Ahonen; Thomas Sparholt Dyrlund; Heli Siljander; Heikki Hyöty; Jorma Ilonen; Jorma Toppari; Riitta Veijola; Tuulia Hyötyläinen; Mikael Knip; Matej Orešič
Journal:  Sci Data       Date:  2018-11-13       Impact factor: 6.444

5.  Circulating metabolites in progression to islet autoimmunity and type 1 diabetes.

Authors:  Santosh Lamichhane; Esko Kemppainen; Kajetan Trošt; Heli Siljander; Heikki Hyöty; Jorma Ilonen; Jorma Toppari; Riitta Veijola; Tuulia Hyötyläinen; Mikael Knip; Matej Orešič
Journal:  Diabetologia       Date:  2019-08-23       Impact factor: 10.122

6.  Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression.

Authors:  Louis-Pascal Xhonneux; Oliver Knight; Åke Lernmark; Ezio Bonifacio; William A Hagopian; Marian J Rewers; Jin-Xiong She; Jorma Toppari; Hemang Parikh; Kenneth G C Smith; Anette-G Ziegler; Beena Akolkar; Jeffrey P Krischer; Eoin F McKinney
Journal:  Sci Transl Med       Date:  2021-03-31       Impact factor: 19.319

7.  Dynamics of Plasma Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes - Type 1 Diabetes Prediction and Prevention Study (DIPP).

Authors:  Santosh Lamichhane; Linda Ahonen; Thomas Sparholt Dyrlund; Esko Kemppainen; Heli Siljander; Heikki Hyöty; Jorma Ilonen; Jorma Toppari; Riitta Veijola; Tuulia Hyötyläinen; Mikael Knip; Matej Oresic
Journal:  Sci Rep       Date:  2018-07-13       Impact factor: 4.379

8.  Cord-Blood Lipidome in Progression to Islet Autoimmunity and Type 1 Diabetes.

Authors:  Santosh Lamichhane; Linda Ahonen; Thomas Sparholt Dyrlund; Alex M Dickens; Heli Siljander; Heikki Hyöty; Jorma Ilonen; Jorma Toppari; Riitta Veijola; Tuulia Hyötyläinen; Mikael Knip; Matej Oresic
Journal:  Biomolecules       Date:  2019-01-21

Review 9.  Human Leukocyte Antigen (HLA) and Islet Autoantibodies Are Tools to Characterize Type 1 Diabetes in Arab Countries: Emphasis on Kuwait.

Authors:  Mohamed Jahromi; Ebaa Al-Ozairi
Journal:  Dis Markers       Date:  2019-11-20       Impact factor: 3.434

10.  Metabolic alterations in immune cells associate with progression to type 1 diabetes.

Authors:  Partho Sen; Alex M Dickens; María Asunción López-Bascón; Tuomas Lindeman; Esko Kemppainen; Santosh Lamichhane; Tuukka Rönkkö; Jorma Ilonen; Jorma Toppari; Riitta Veijola; Heikki Hyöty; Tuulia Hyötyläinen; Mikael Knip; Matej Orešič
Journal:  Diabetologia       Date:  2020-02-11       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.